Randomized comparison of pazopanib and doxorubicin as first-line treatment in patients with metastatic soft tissue sarcoma age 60 years or older: results of a German intergroup study - Grünwald, Viktor; Karch, Annika; Schuler, Markus; Schöffski, Patrick; Kopp, Hans-Georg; Bauer, Sebastian; Kasper, Bernd; Lindner, Lars H.; Chemnitz, Jens-Marcus; Crysandt, Martina; Stein, Alexander; Steffen, Björn; et al. (Journal of clinical oncology, 2020)
Gesehen am 22.04.2021